[The toxicity and pharmacologic properties of rifamycin SV].
D000818:Animals; D001341:Autonomic Nervous System / Q000187:drug effects; D001772:Blood Cell Count; D001786:Blood Glucose / Q000032:analysis; D001794:Blood Pressure / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects; D002415:Cats; D004231:Diuresis / Q000187:drug effects; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D051379:Mice; D009469:Neuromuscular Junction / Q000187:drug effects; D009929:Organ Size; D011188:Potassium / Q000097:blood; D051381:Rats; D012119:Respiration / Q000187:drug effects; D012294:Rifamycins / Q000494:pharmacology / Q000633:toxicity*; D012964:Sodium / Q000097:blood; D000637:Transaminases / Q000097:blood; D014508:Urea / Q000097:blood
D001786:Blood Glucose; D012294:Rifamycins; D014508:Urea; D012964:Sodium; D000637:Transaminases; D011188:Potassium
Izuchenie toksichnosti i farmakologicheskikh svoĭstv rifamitsina SV